GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Inventory-to-Revenue

Meribank Biotech Co (ROCO:4724) Inventory-to-Revenue : 0.07 (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Meribank Biotech Co's Average Total Inventories for the quarter that ended in Jun. 2024 was NT$8.5 Mil. Meribank Biotech Co's Revenue for the six months ended in Jun. 2024 was NT$130.3 Mil. Meribank Biotech Co's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.07.

Meribank Biotech Co's Inventory-to-Revenue for the quarter that ended in Jun. 2024 increased from Dec. 2023 (0.06) to Dec. 2023 (0.07)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Meribank Biotech Co's Days Inventory for the six months ended in Jun. 2024 was 31.91.

Inventory Turnover measures how fast the company turns over its inventory within a year. Meribank Biotech Co's Inventory Turnover for the quarter that ended in Jun. 2024 was 5.72.


Meribank Biotech Co Inventory-to-Revenue Historical Data

The historical data trend for Meribank Biotech Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Inventory-to-Revenue Chart

Meribank Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue
Get a 7-Day Free Trial 0.02 0.01 0.02 0.03 0.03

Meribank Biotech Co Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.07 0.08 0.06 0.07

Competitive Comparison of Meribank Biotech Co's Inventory-to-Revenue

For the Biotechnology subindustry, Meribank Biotech Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Meribank Biotech Co's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Meribank Biotech Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Meribank Biotech Co's Inventory-to-Revenue falls into.



Meribank Biotech Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Meribank Biotech Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (8.446 + 6.907) / 2 ) / 234.342
=7.6765 / 234.342
=0.03

Meribank Biotech Co's Inventory-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue (Q: Jun. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Jun. 2024 )) / count ) / Revenue (Q: Jun. 2024 )
=( (6.907 + 10.096) / 2 ) / 130.328
=8.5015 / 130.328
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meribank Biotech Co  (ROCO:4724) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Meribank Biotech Co's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2024 )/Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=8.5015/48.616*365 / 2
=31.91

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Meribank Biotech Co's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2024 ) / Average Total Inventories (Q: Jun. 2024 )
=48.616 / 8.5015
=5.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Meribank Biotech Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Meribank Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493
Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co Headlines

No Headlines